Description
PRINCIPIO ACTIVO: INSULINA BIFASICA ASPARTICA
Eli Lilly and Company — Estados Unidos
XOLAIR® 150 mg/1
PRINCIPIO ACTIVO: PIROXICAM 0
Cada jeringa contiene 6 mg de pegfilgrastim
NOSIPREN TAB. 20 MG. CAJA C/30 OXIBUTININA CLORHIDRATO DE PRINCIPIO ACTIVO: INSULINA BIFASICA ASPARTICASUSTANCIA: NOSIPREN TAB. 20 MG. CAJA C 30 FABRICANTE: COLLINS
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
DOLXEN TAB. 500 MG. CAJA C/10 HIDRASMINA
US$ 25.91
GLIOZAC TAB. 30 MG. CAJA C/7 FRAMBUESA
US$ 38.09
NOVAGON PVO. FCO. C/400 G. receta
US$ 124.10
recommand products
